MorphoSys AG Cash Flow Statement

Financials in millions CAD. Fiscal year is December - November.

Millions CAD. Fiscal year is Dec - Nov.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2020
Period Ending	May '25 May 31, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	2018 - 2020
Net Income	-2.47	-0.36	-0.28	-0.24	-0.4	-0.28	Upgrade
Depreciation & Amortization	2.12	0.03	0.03	-	-	-	Upgrade
Stock-Based Compensation	0.11	0.1	-	-	0.18	-	Upgrade
Change in Accounts Payable	-0.01	0.01	-0	-0	-0	0.01	Upgrade
Change in Other Net Operating Assets	-0	-0.02	0	-0.01	0.03	-0.04	Upgrade
Operating Cash Flow	-0.26	-0.25	-0.25	-0.25	-0.18	-0.31	Upgrade
Capital Expenditures	-0.19	-0.26	-0.18	-0.07	-0.03	-0.52	Upgrade
Other Investing Activities	-	-	-	-	0.05	-0.03	Upgrade
Investing Cash Flow	-0.19	-0.26	-0.18	-0.07	0.02	-0.55	Upgrade
Issuance of Common Stock	0.44	0.74	0.14	0.31	-	0.9	Upgrade
Financing Cash Flow	0.44	0.74	0.14	0.31	-	0.9	Upgrade
Net Cash Flow	-0	0.23	-0.29	-0.01	-0.16	0.04	Upgrade
Free Cash Flow	-0.44	-0.52	-0.43	-0.32	-0.21	-0.83	Upgrade
Free Cash Flow Per Share	-0.01	-0.01	-0.01	-0.01	-0.01	-0.03	Upgrade
Levered Free Cash Flow	-	-0.37	-0.31	-0.23	-0.01	-0.75	Upgrade
Unlevered Free Cash Flow	-	-0.37	-0.31	-0.23	-0.01	-0.75	Upgrade
Change in Working Capital	-0.01	-0.01	0	-0.01	0.03	-0.03	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.